Capraria biflora Extract for Senile Cataract Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for senile cataracts are largely surgical, carrying risks and complications, and there is a need for a non-surgical method to prevent or treat cataracts in both humans and animals effectively.
Innovation Solution
An aqueous extract of Capraria biflora is used to create a stable ophthalmic solution that can be administered topically, systemically, or intraocularly to prevent or retard the development of senile cataracts, either as a treatment for existing cataracts or as a prophylactic measure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If cataract extraction surgery is performed, then vision is improved, but surgical risks and complications increase
Solution Approach 1:
The patent replaces the mechanical surgical intervention (cataract extraction) with a chemical/biological solution (aqueous extract administration). The extract contains active compounds that chemically interact with the lens opacity, dissolving or breaking down the cataract material without mechanical removal, thereby eliminating surgical risks while maintaining vision improvement benefits
Solution Approach 2:
The aqueous extract acts as an intermediary substance between the external environment and the cataract-affected lens. The extract contains mediator compounds that penetrate the eye and interact with the lens opacity, facilitating the removal of cataracts through chemical action rather than direct mechanical intervention, thus reducing surgical complications
2Object-affected harmful factors
If cataract extraction surgery is performed, then lens opacity is removed, but post-surgical complications may occur
Solution Approach 1:
The patent converts the harmful lens opacity into a treatable condition through chemical dissolution. The aqueous extract contains compounds that specifically target and break down the opaque protein structures in the cataract, transforming the harmful opacity into soluble products that can be naturally eliminated, thereby removing the need for surgical intervention and its associated complications
Solution Approach 2:
The treatment enables the eye's natural systems to handle cataract removal without external surgical intervention. The aqueous extract facilitates the body's own enzymatic and metabolic processes to dissolve and eliminate the cataract material, allowing the physiological system to service itself rather than requiring invasive medical procedures that could generate post-surgical complications
3Reliability
If non-surgical treatment is developed, then surgical risks are eliminated, but treatment effectiveness must be proven
Solution Approach 1:
The patent employs preliminary in-vivo experiments and clinical trials to validate the treatment efficacy before widespread application. These preliminary actions demonstrate that the aqueous extract effectively reduces lens opacity and improves vision, providing measurable evidence of treatment effectiveness that establishes confidence in the non-surgical approach's reliability
Data Source
AI summary
The invention provides methods for treating and/or preventing the recurrence of a senile cataract, and/or for inhibiting the development of a senile cataract and/or an incipient senile cataract, in a human or animal subject. The invention further provides nutraceutical compositions suited for the same, derived from an extract of the plant Capraria biflora. The compositions comprise the extract in a therapeutically sufficient amount for the treatment and/or prophylaxis of a senile cataract in a human and/or animal subject.